Study highlights the link between urinary and vaginal pathogenic E. coli in recurrent cystitis

FHS
July 19, 2024
11:38 pm

The human body hosts a diverse array of microorganisms that maintain a delicate balance crucial for overall health.

Takeda receives US FDA approval for HYQVIA to treat CIDP

Share this article Takeda’s HYQVIA is intended to be used as a maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy. Credit: Melnikov Dmitriy /

January 17, 2024

New technology streamlines drug discovery using single-molecule tracking

New drug discovery is a critical step for improving patients’ lives. First, researchers must identify molecules in the body’s cells that help drive disease, as

November 1, 2024

Introducing Post-Hoc: Our latest newsletter with analysis and insights

This week, we’re launching Post-Hoc. Written by our reporters and editors, Post-Hoc is a weekly(ish) piece of analysis that follows big news, an insight from the

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.